{"entity":{"type":"insider","cik":"0001845080","url":"/insider/0001845080","json_url":"/insider/0001845080.json","name":"Lee Philina","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2023-03-08","last":"2025-03-07","span_basis":"filed_date"},"name_variants":[{"name":"Lee Philina","source":"filing","n_filings":5,"first_seen":"2023-03-08","last_seen":"2025-03-07"}],"transactions":[{"id":5038703,"accession":"0001415889-25-007396","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-007396","line_url":"/filing/0001415889-25-007396#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001845080","owner_name":"Lee Philina","owner_display_name":"Lee Philina","owner_url":"/insider/0001845080","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3733.0,"shares_display":"3,733","price_per_share":88.8,"price_display":"88.80","price_state":"stated","total_value":331490.4,"total_display":"331,490.40","total_whole":"331,490","shares_owned_after":41996.0,"shares_owned_after_display":"41,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":2807017,"accession":"0001415889-24-020928","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-24-020928","line_url":"/filing/0001415889-24-020928#line-8","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001845080","owner_name":"Lee Philina","owner_display_name":"Lee Philina","owner_url":"/insider/0001845080","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41913.0,"shares_display":"41,913","price_per_share":93.19,"price_display":"93.19","price_state":"stated","total_value":3905872.47,"total_display":"3,905,872.47","total_whole":"3,905,872","shares_owned_after":34729.0,"shares_owned_after_display":"34,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-05","filed_date":"2024-08-07","scope":"insider"},{"id":2862559,"accession":"0001415889-24-008124","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-008124","line_url":"/filing/0001415889-24-008124","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001845080","owner_name":"Lee Philina","owner_display_name":"Lee Philina","owner_url":"/insider/0001845080","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8023.0,"shares_display":"8,023","price_per_share":90.39968216377913,"price_display":"90.40","price_state":"stated","total_value":725276.65,"total_display":"725,276.65","total_whole":"725,277","shares_owned_after":36529.0,"shares_owned_after_display":"36,529","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-13","filed_date":"2024-03-15","scope":"insider","n_lines":2},{"id":2995712,"accession":"0001415889-24-007559","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-007559","line_url":"/filing/0001415889-24-007559#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001845080","owner_name":"Lee Philina","owner_display_name":"Lee Philina","owner_url":"/insider/0001845080","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2934.0,"shares_display":"2,934","price_per_share":90.69,"price_display":"90.69","price_state":"stated","total_value":266084.46,"total_display":"266,084.46","total_whole":"266,084","shares_owned_after":41005.0,"shares_owned_after_display":"41,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider"},{"id":8612720,"accession":"0001415889-23-004562","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-004562","line_url":"/filing/0001415889-23-004562","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001845080","owner_name":"Lee Philina","owner_display_name":"Lee Philina","owner_url":"/insider/0001845080","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1676.0,"shares_display":"1,676","price_per_share":45.67747016706444,"price_display":"45.68","price_state":"stated","total_value":76555.44,"total_display":"76,555.44","total_whole":"76,555","shares_owned_after":31232.0,"shares_owned_after_display":"31,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001597264","name":"Blueprint Medicines Corp","url":"/issuer/0001597264","role":"Officer (CHIEF COMMERCIAL OFFICER)","n_filings":5,"first_seen":"2023-03-08","last_seen":"2025-03-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001845080","retrieved_at":"2026-08-24T23:53:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}